Please login to the form below

INFOSHEET 02: Improving diversity in your patient recruitment strategy

As inclusion and diversity advocates, we design and implement recruitment strategies that break down participant barriers.

As ethnic and religious minorities remain under-represented in clinical studies globally, and enrolment remains your biggest challenge, the connection between the two shouldn’t go unnoticed.

Barriers to recruitment can be economic, linguistic, cultural, religious or physical. And in many cases, patients are referred by doctors or medical centres, which have a higher percentage of certain demographics than others. But with regulatory bodies around the world increasingly asking for evidence of drug safety and effectiveness in diverse populations, it’s vital to address these barriers in your clinical study design.

How a lack of diversity affects outcomes

Differences between people, such as:

  • age
  • gender
  • weight
  • ethnicity
  • geographical location

can affect clinical outcomes. Different groups may need alternative drug dosages, experience completely different results, and have distinctive side effects. Without a diverse participant pool, these metrics can’t be fully explored, meaning outcomes will be unknown.

Widen your participant pool to improve enrolment targets

Improving diversity in clinical studies brings huge benefits. For research companies, facilitating minority patients to enrol on your study means you’ll have a much broader patient pool to recruit participants from.

Help improve health equity and safety

By enrolling minority patients in your studies, you can improve the likelihood that they’ll benefit from the research. The results of the studies will be relevant to more segments of the population, and can help improve access to healthcare services generally, meaning better health equity for everybody. Plus, medical products are safer and more effective for a wider population when clinical research includes diverse populations.

How to design a diverse and inclusive clinical study

Developing relationships with patient advocacy groups is vital to the success of any clinical study. If your study needs to reach an established patient group, or a minority population, then you’ve got to engage community leaders, patient advocates, and key opinion leaders throughout the development process. By developing these relationships with your target population, your study will be welcomed and trusted.

At COUCH Health, we champion the need to improve diversity in clinical studies. Firstly, because we believe that there’s no excuse that this remains an issue in today’s modern world. And secondly, because clinical studies that enrol racially and ethnically diverse patients supports an increase in safe drugs for a representative patient population.

If you’d like to hear more about what we do, or would like to discuss how we could improve diversity and inclusion in your clinical studies, contact us here.

20th July 2020

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021.
COUCH Health
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs.
COUCH Health
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial is about and to ensure consent is informed. And be something that people are going to remember. And with some trials lasting years, building awareness and familiarity is key to improve engagement. That’s where your clinical trial branding comes in…
COUCH Health
October 2020: diversity and inclusion in clinical trials round-up
In our latest round-up of news surrounding diversity and inclusion in clinical trials, we take a closer look into the benefits that diversity can bring to society, learnings that we can take from the COVID-19 pandemic to shift our thinking around diversity and clinical trials, how we can address long-standing barriers to build trust in healthcare, and much more.
COUCH Health
Live panel discussion: Should diverse representation in UK clinical trials be mandatory?
This online event is being held by Innovative Trials, COUCH Health, and Egality Health.  Three organisations who are working to improve diversity in clinical trials.
COUCH Health
What are the biggest barriers in patient recruitment?
With the advances that have been made in clinical research, it’s almost hard to believe that the same challenges still exist within patient recruitment. Unfortunately, traditional clinical research models pose challenges at many levels and ultimately hinder the efficient running of clinical trials.
COUCH Health